Literature DB >> 6185699

Serum prostatic antigen measurement in localized prostatic cancer: correlation with clinical course.

J E Pontes, T M Chu, N Slack, J Karr, G P Murphy.   

Abstract

Serial serum prostatic antigen measurements were performed on patients treated for localized prostatic carcinoma. There was good correlation of mean serum prostatic antigen levels and the surgical stage of the disease. Among patients treated by radical prostatectomy there was good correlation of an elevated serum prostatic antigen and the development of metastatic disease. It appears that serum prostatic antigen is a good indicator and predictor of the development of distant metastasis in this group of patients.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6185699     DOI： 10.1016/s0022-5347(17)53431-x

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  4 in total

1.  Prostate-specific antigen. Superior serum marker for prostatic carcinoma.

Authors:  J A Heaney; M A Allen; T Keane; M J Duffy
Journal:  Ir J Med Sci       Date:  1987-05       Impact factor: 1.568

2.  Temporal changes in the clinical approach to diagnosing prostate cancer.

Authors:  William M Hilton; Susan S Padalecki; Donna P Ankerst; Robin J Leach; Ian M Thompson
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

3.  Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen.

Authors:  H Fuse; K Umeda; I Mizuno; T Katayama
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

4.  Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour.

Authors:  S Q Maddy; G D Chisholm; A Busuttil; F K Habib
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.